BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 16394059)

  • 1. Azithromycin extended-release (Zmax) for sinusitis and pneumonia.
    Obstet Gynecol; 2006 Jan; 107(1):180-2. PubMed ID: 16394059
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparative randomized trial of azithromycin versus erythromycin and amoxicillin for treatment of community-acquired pneumonia in children.
    Kogan R; Martínez MA; Rubilar L; Payá E; Quevedo I; Puppo H; Girardi G; Castro-Rodriguez JA
    Pediatr Pulmonol; 2003 Feb; 35(2):91-8. PubMed ID: 12526069
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Azithromycin extended-release (Zmax) for sinusitis and pneumonia.
    Med Lett Drugs Ther; 2005 Sep; 47(1218):78-80. PubMed ID: 16186790
    [No Abstract]   [Full Text] [Related]  

  • 4. Azithromycin versus comparative therapy for the treatment of community acquired pneumonia.
    Rahav G; Fidel J; Gibor Y; Shapiro M
    Int J Antimicrob Agents; 2004 Aug; 24(2):181-4. PubMed ID: 15288319
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gemifloxacin once daily for 5 days versus 7 days for the treatment of community-acquired pneumonia: a randomized, multicentre, double-blind study.
    File TM; Mandell LA; Tillotson G; Kostov K; Georgiev O
    J Antimicrob Chemother; 2007 Jul; 60(1):112-20. PubMed ID: 17537866
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is azithromycin monotherapy as efficacious as cefuroxime plus erythromycin for the treatment of community-acquired pneumonia in hospitalized patients?
    See S
    J Fam Pract; 2000 Oct; 49(10):883-4. PubMed ID: 11052155
    [No Abstract]   [Full Text] [Related]  

  • 7. Onset of symptom resolution in adults with acute bacterial rhinosinusitis treated with a single dose of azithromycin extended release compared with 10 days of levofloxacin: a retrospective analysis of a randomized, double-blind, double-dummy trial.
    Marple BF; Roberts CS; de Caprariis PJ; Reisman A
    Clin Ther; 2007 Dec; 29(12):2690-8. PubMed ID: 18201585
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Community-acquired pneumonia: is it time to shorten the antibiotic treatment?
    Esposito S; Fiore M
    Expert Rev Anti Infect Ther; 2007 Dec; 5(6):933-8. PubMed ID: 18039078
    [No Abstract]   [Full Text] [Related]  

  • 9. Community-acquired respiratory infections: spectrum of organisms and treatment.
    McKellar PP
    J Med Liban; 2000; 48(4):264-9. PubMed ID: 11214199
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Community acquired pneumonia.
    Al-Qadi MO; Al-Alwan A; Opal SM; Cillley B; Silverblatt FJ
    Med Health R I; 2010 Jul; 93(7):196-200. PubMed ID: 20707009
    [No Abstract]   [Full Text] [Related]  

  • 11. Is it possible to blind a trial for community-acquired pneumonia?
    Boucher HW
    Clin Infect Dis; 2008 Dec; 47 Suppl 3():S210-5. PubMed ID: 18986292
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Recommendations for therapy of community-acquired pneumonia. German Society of Pneumology].
    Schaberg T; Dalhoff K; Ewig S; Lorenz J; Wilkens H
    Pneumologie; 1998 Aug; 52(8):450-62. PubMed ID: 9774872
    [No Abstract]   [Full Text] [Related]  

  • 13. Azithromycin extended release: a review of its use in the treatment of acute bacterial sinusitis and community-acquired pneumonia in the US.
    Swainston Harrison T; Keam SJ
    Drugs; 2007; 67(5):773-92. PubMed ID: 17385947
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Azithromycin and lower respiratory tract infections.
    Blasi F; Cazzola M; Tarsia P; Cosentini R; Aliberti S; Santus P; Allegra L
    Expert Opin Pharmacother; 2005 Oct; 6(13):2335-51. PubMed ID: 16218893
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of a novel, single-dose azithromycin microsphere formulation versus 10 days of levofloxacin for the treatment of acute bacterial sinusitis in adults.
    Murray JJ; Emparanza P; Lesinskas E; Tawadrous M; Breen JD
    Otolaryngol Head Neck Surg; 2005 Aug; 133(2):194-200. PubMed ID: 16087013
    [TBL] [Abstract][Full Text] [Related]  

  • 16. How long should we treat community-acquired pneumonia?
    Scalera NM; File TM
    Curr Opin Infect Dis; 2007 Apr; 20(2):177-81. PubMed ID: 17496577
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Antibiotic therapy of bronchial infections. 2: Community acquired and nosocomial pneumonias].
    Buchenroth M
    MMW Fortschr Med; 1999 Dec; 141(49-50):48-50. PubMed ID: 10726149
    [No Abstract]   [Full Text] [Related]  

  • 18. Tailored interventions to improve antibiotic use for lower respiratory tract infections in hospitals: a cluster-randomized, controlled trial.
    Schouten JA; Hulscher ME; Trap-Liefers J; Akkermans RP; Kullberg BJ; Grol RP; van der Meer JW
    Clin Infect Dis; 2007 Apr; 44(7):931-41. PubMed ID: 17342644
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics of azithromycin in serum and sinus fluid after administration of extended-release and immediate-release formulations in patients with acute bacterial sinusitis.
    Ehnhage A; Rautiainen M; Fang AF; Sanchez SP
    Int J Antimicrob Agents; 2008 Jun; 31(6):561-6. PubMed ID: 18456465
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drugs of choice for community-acquired bacterial pneumonia.
    Med Lett Drugs Ther; 2007 Jul; 49(1266):62-4. PubMed ID: 17652999
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.